Research Article
Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal 18F-FES PET/CT
Figure 4
Quantitative analysis of 18F-FES uptake %ID/gmax (a) and the change Δ%ID/gmax (b) from the microPET/CT imaging on days 0, 3, 14, and 21 after treatment. , , within groups compared to baseline; , between treatment and vehicle groups.
(a) |
(b) |